Skip to main content
OpenTrials
Completed

NCT Number: NCT06357130

Gynaecological Care for Transgender People in France in 2024.

To date, the transgender population, still poorly characterized, tends to increase. The impact of gender-affirming hormone therapy (GAHT) in this population remains poorly understood, and few data are published on the gynecological repercussions of such therapy. A recent literature review by a French team suggests gynecological follow-up procedures for transgender people.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Transgender Management Care Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hopital Haut-Lévêque

Pessac, 33604, France

About this study

The hypothesis of this study is that transgender population in France does not have appropriate gynecological care, and the study would like to find out, directly from the people concerned, the current state of gynecological care for transgender people in France. To do this, ths study plan to send out a questionnaire to transgender people (via healthcare networks and also transgender associations) to ask them about their actual gynecological care and their knowledge of recommended gynecological care.

The aim is to set up a descriptive, declarative study based on a questionnaire created specifically for this work.

This project will use a questionnaire for transwomen people and another one for transmen people. Transgender people will be approached via Trans associations and healthcare networks. An online link to the questionnaire will be sent to trans associations and healthcare networks for distribution to the target population thanks to a flyer.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • French-speaking transgender person (transgender women or transgender men)
  • age ≥18 years

Exclusion criteria

  • age <18 years

Treatment and study plan

Questionnaire

Other

A flyer with QR code leading to the online questionnaire will be sent to trans associations and healthcare networks for distribution to the target population.

Primary outcomes

  1. Percentage of people aware of gynaecological recommendations.

    Time frame: 24 months after inclusion day

    Percentage of transgender people who know regular gynaecological recommendations in France, thanks to a homemade questionnaire

Secondary outcomes

  1. Percentage of people aware of cancer risks

    Time frame: 24 months after inclusion day

    Overview of organized screening for gynaecological cancers and prostate cancer in the transgender population, thanks to a homemade questionnaire

  2. Percentage of people aware of contraception in transgender male population

    Time frame: 24 months after inclusion day

    Overview of knowledge about contraception in the transgender male population,thanks to a homemade questionnaire.

  3. Percentage of people aware of fertility and the impact of hormone treatments

    Time frame: 24 months after inclusion day

    Overview of knowledge about fertility and the impact of hormone treatments in the transgender population, thanks to a homemade questionnaire.

  4. Percentage of people aware of gynaecological repercussions of masculinizing hormone treatment in transgender male population

    Time frame: 24 months after inclusion day

    Overview of our knowledge of the gynaecological repercussions of masculinizing hormone treatment in the transgender male population, thanks to a homemade questionnaire.

Sponsors and collaborators

Lead sponsor

University Hospital, Bordeaux

Other

Registry information

Acronym: GyneTrans

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Apr 10, 2024
Registry last updated
Jun 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.